Simplex Trading’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-600
| Closed | -$15.5K | – | 9875 |
|
|
2025
Q4 | $15.5K | Sell |
600
-600
| -50% | -$14.3K | ﹤0.01% | 6690 |
|
|
2025
Q3 | $30K | Hold |
1,200
| – | – | ﹤0.01% | 6983 |
|
|
2025
Q2 | $28K | Buy |
1,200
+700
| +140% | +$17.6K | ﹤0.01% | 6472 |
|
|
2025
Q1 | $12K | Sell |
500
-10,600
| -95% | -$254K | ﹤0.01% | 6988 |
|
|
2024
Q4 | $209K | Sell |
11,100
-2,700
| -20% | -$47.4K | ﹤0.01% | 4468 |
|
|
2024
Q3 | $207K | Buy |
13,800
+4,700
| +52% | +$80.4K | ﹤0.01% | 4486 |
|
|
2024
Q2 | $260K | Buy |
9,100
+7,200
| +379% | +$205K | ﹤0.01% | 4386 |
|
|
2024
Q1 | $55K | Sell |
1,900
-42,500
| -96% | -$1.31M | ﹤0.01% | 6183 |
|
|
2023
Q4 | $1.5M | Buy |
44,400
+32,900
| +286% | +$963K | ﹤0.01% | 2621 |
|
|
2023
Q3 | $352K | Buy |
11,500
+7,000
| +156% | +$252K | ﹤0.01% | 3769 |
|
|
2023
Q2 | $180K | Buy |
4,500
+3,400
| +309% | +$141K | ﹤0.01% | 4421 |
|
|
2023
Q1 | $44K | Sell |
1,100
-6,000
| -85% | -$239K | ﹤0.01% | 6068 |
|
|
2022
Q4 | $274K | Buy |
7,100
+3,400
| +92% | +$165K | ﹤0.01% | 3853 |
|
|
2022
Q3 | $196K | Buy |
3,700
+1,400
| +61% | +$77.9K | ﹤0.01% | 4635 |
|
|
2022
Q2 | $134K | Buy |
2,300
+1,000
| +77% | +$65.5K | ﹤0.01% | 5164 |
|
|
2022
Q1 | $99K | Sell |
1,300
-1,600
| -55% | -$107K | ﹤0.01% | 6166 |
|
|
2021
Q4 | $174K | Buy |
2,900
+2,200
| +314% | +$121K | ﹤0.01% | 5388 |
|
|
2021
Q3 | $41K | Hold |
700
| – | – | ﹤0.01% | 7760 |
|
|
2021
Q2 | $42K | Buy |
700
+692
| +8,650% | +$43.8K | ﹤0.01% | 7869 |
|
|
2021
Q1 | $56K | Sell |
8
-4
| -33% | -$286 | ﹤0.01% | 6469 |
|
|
2020
Q4 | $71K | Buy |
12
+2
| +20% | +$117 | ﹤0.01% | 5793 |
|
|
2020
Q3 | $60K | Sell |
10
-31
| -76% | -$1.8K | ﹤0.01% | 5435 |
|
|
2020
Q2 | $215K | Buy |
41
+22
| +116% | +$919 | ﹤0.01% | 3918 |
|
|
2020
Q1 | $63K | Sell |
19
-27
| -59% | -$1.12K | ﹤0.01% | 4891 |
|
|
2019
Q4 | $208K | Sell |
46
-313
| -87% | -$13.3K | ﹤0.01% | 3708 |
|
|
2019
Q3 | $1.37M | Buy |
359
+167
| +87% | +$6.67K | ﹤0.01% | 1660 |
|
|
2019
Q2 | $835K | Buy |
192
+185
| +2,643% | +$7.85K | ﹤0.01% | 2069 |
|
|
2019
Q1 | $26K | Sell |
7
-38
| -84% | -$1.48K | ﹤0.01% | 5536 |
|
|
2018
Q4 | $193K | Sell |
45
-113
| -72% | -$5.28K | ﹤0.01% | 3198 |
|
|
2018
Q3 | $776K | Buy |
158
+141
| +829% | +$6.09K | ﹤0.01% | 2140 |
|
|
2018
Q2 | $54K | Buy |
+17
| New | +$587 | ﹤0.01% | 4970 |
|
|
2018
Q1 | – | Sell |
-189
| Closed | -$133K | – | 6677 |
|
|
2017
Q4 | $133K | Buy |
189
+171
| +950% | +$6.78K | 0.01% | 1582 |
|
|
2017
Q3 | $1K | Buy |
+18
| New | +$724 | ﹤0.01% | 5534 |
|
|
2017
Q2 | – | Sell |
-311
| Closed | -$199K | – | 6607 |
|
|
2017
Q1 | $199K | Buy |
+311
| New | +$13.4K | 0.01% | 1203 |
|
|
2016
Q4 | – | Sell |
-107
| Closed | -$7K | – | 6346 |
|
|
2016
Q3 | $7K | Buy |
107
+82
| +328% | +$3.21K | ﹤0.01% | 3964 |
|
|
2016
Q2 | $3K | Sell |
25
-2
| -7% | -$98 | ﹤0.01% | 4675 |
|
|
2016
Q1 | $9K | Sell |
27
-201
| -88% | -$11.8K | ﹤0.01% | 3586 |
|
|
2015
Q4 | $66K | Sell |
228
-46
| -17% | -$2.6K | 0.01% | 1693 |
|
|
2015
Q3 | $11K | Buy |
274
+248
| +954% | +$15.2K | ﹤0.01% | 3349 |
|
|
2015
Q2 | $2K | Sell |
26
-32
| -55% | -$2.52K | ﹤0.01% | 4325 |
|
|
2015
Q1 | $14K | Buy |
58
+8
| +16% | +$812 | ﹤0.01% | 2632 |
|
|
2014
Q4 | $30K | Buy |
+50
| New | +$4.73K | ﹤0.01% | 1751 |
|
Other funds holding PCRX
DPCM
VPM
VCM
Simplex Trading's PCRX Position: Q1 2026 in Review
Simplex Trading opened a new position in Pacira BioSciences (PCRX) in Q1 2026: 56 shares worth $1.26K. The stake represents ﹤0.01% of the portfolio and ranks #8520 among its holdings. This is a return to the name: Simplex Trading previously reported a position in PCRX as recently as Q2 2025.
Simplex Trading first reported a position in PCRX in Q3 2015 and has held it in 22 quarters since. The position peaked at $1.43M in Q4 2018. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.
- Simplex Trading held 56 shares of Pacira BioSciences worth $1.26K as of Q1 2026.
- Pacira BioSciences was a new Simplex Trading position in Q1 2026.
- Pacira BioSciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8520 holding.
- Simplex Trading first reported a position in Pacira BioSciences in Q3 2015 and has held it in 22 quarters since.
- Simplex Trading's Pacira BioSciences position peaked at $1.43M in Q4 2018.
- 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.